🇺🇸 FDA
Pipeline program

epoprostenol

199/11678

Approved small_molecule completed

Quick answer

epoprostenol for Hypertension, Pulmonary is a Approved program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Hypertension, Pulmonary
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials